Diagnosed focal or generalized epilepsy with depressive symptoms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged = 18 years of age 2. Patients are capable of consent themselves and/or have a legal guardian 3. The patients themselves use their own Android smartphones or consent to switching to a study-related Android smartphone at the test center. The Android smartphone must have at least Android version 6 of the operating system. 4. Diagnosed focal or generalized epilepsy with depressive symptoms determined with the BDI-2 (= 9 points) 5. There is a current treatment in the video-EEG monitoring unit of at least 24 hours
Exclusion criteria
Exclusion criteria: 1. There is currently an acute self-endangerment (one month before inclusion). 2. There is a lifetime diagnosis of a psychotic illness (every diagnosis according to DRG F20.X), every bipolar illness (F31.X), every borderline personality disorder 3. In the case of a lifetime diagnosis of substance abuse: in stable remission (at least 6 months) 4. Patients have a cardiac pacemaker or other implanted device (eg, VNS, ICD) 5. Patients have a known or suspected allergy to the materials of the device used or to the electrodes used. 6. Patients who are currently pregnant. This fact is recorded during anamnesis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is "Association between seizure frequency and depressive symptoms as measured by PHQ-9 and BDI-II". | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoint is parameters such as sleep, step count, exercise, and voice modulation predict the individual extent of depressive symptoms. | — |
Countries
Germany
Contacts
Uniklinik RWTH Aachen